Key facts
- It has raised $60K; the latest was Angel (individual) ($60K) in Mar 2026.
- Notable investors include Touker Suleyman.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Albus & Flora
- ·The full record, as it builds
Funding rounds
No funding rounds for Albus & Flora are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Albus & Flora
Manufacturer of skincare products designed for the care of lips and the surrounding skin. The company develops topical formulations that include lip treatment creams, protective balms with sun protection, tinted protective products, and bundled treatment routines, incorporates active cosmetic ingredients, botanical components and biotechnology-based compounds, provides products intended for hydration, barrier protection and maintenance of lip skin condition, distributes items through an online retail store and spa or clinic partners, enabling consumers and skincare practitioners to access products for routine lip care and protection against dryness and environmental exposure.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Nelson, United Kingdom
- Founded
- 2013
- Employees
- 4
- Website
- albusandflora.com/
- Ownership
- Privately Held (backing)
Albus & Flora doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Albus & Flora shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Albus & Flora in its N-PORT filings yet. We sweep new filings monthly.